We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+46.47%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$69.8M
Cap. Flow
-$22.2M
Cap. Flow %
-5.45%
Top 10 Hldgs %
24.1%
Holding
129
New
20
Increased
20
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
VCYT icon
Veracyte
VCYT
+$8.34M
2
TWST icon
Twist Bioscience
TWST
+$6.32M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$5.16M
4
PACB icon
Pacific Biosciences
PACB
+$5.1M
5
TDOC icon
Teladoc Health
TDOC
+$4.41M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$11.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.49M
3
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$6.86M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$5.86M
5
ARWR icon
Arrowhead Research
ARWR
+$5.76M

Sector Composition

Rank Sector Weight
1 Healthcare 45.15%
2 Technology 24.29%
3 Communication Services 9.57%
4 Consumer Discretionary 5.1%
5 Financials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
26
Natera
NTRA
$38.6B
$4.98M 1.22%
50,000
-20,000
-29% -$1.67M
SGEN
27
DELISTED
Seagen Inc. Common Stock
SGEN
$4.85M 1.19%
+27,679
New +$5.16M
GPRK icon
28
GeoPark
GPRK
$622M
$4.68M 1.15%
13,042
-11,309
-46% -$107K
CORT icon
29
Corcept Therapeutics
CORT
$12.8B
$4.64M 1.14%
177,300
– –
NVDA icon
30
NVIDIA
NVDA
$4.72T
$4.59M 1.13%
351,320
+80,000
+29% +$1.07M
FSLY icon
31
Fastly Inc
FSLY
$3.37B
$4.37M 1.07%
+50,000
New +$4.41M
CRWD icon
32
CrowdStrike
CRWD
$189B
$4.34M 1.07%
82,000
-22,000
-21% -$857K
DDOG icon
33
Datadog
DDOG
$95.6B
$4.33M 1.06%
44,000
+20,000
+83% +$2M
OTRK
34
DELISTED
Ontrak
OTRK
$4.25M 1.04%
764
– –
TSLA icon
35
Tesla
TSLA
$1.22T
$4.23M 1.04%
18,000
-27,000
-60% -$4.61M
AMRC icon
36
Ameresco
AMRC
$1.09B
$4.22M 1.04%
80,792
– –
NIU
37
Niu Technologies
NIU
$203M
$4.17M 1.02%
148,800
– –
OMCL icon
38
Omnicell
OMCL
$1.69B
$4.07M 1%
33,938
– –
GRWG icon
39
GrowGeneration
GRWG
$87.1M
$4.02M 0.99%
+100,000
New +$2.69M
BLK icon
40
Blackrock
BLK
$170B
$3.92M 0.96%
5,440
– –
OKTA icon
41
Okta
OKTA
$24.4B
$3.81M 0.94%
15,000
+7,500
+100% +$1.78M
IOVA icon
42
Iovance Biotherapeutics
IOVA
$2.09B
$3.71M 0.91%
80,000
– –
ZYXI
43
DELISTED
Zynex
ZYXI
$3.71M 0.91%
303,087
+87,780
+41% +$1.14M
VICR icon
44
Vicor
VICR
$9.42B
$3.62M 0.89%
39,282
– –
IONS icon
45
Ionis Pharmaceuticals
IONS
$8.81B
$3.6M 0.88%
63,707
– –
FRPT icon
46
Freshpet
FRPT
$2.98B
$3.55M 0.87%
25,000
– –
RARE icon
47
Ultragenyx Pharmaceutical
RARE
$2.56B
$3.54M 0.87%
25,582
-25,000
-49% -$2.97M
VRSN icon
48
VeriSign
VRSN
$25.9B
$3.51M 0.86%
16,212
– –
NSP icon
49
Insperity
NSP
$2.06B
$3.44M 0.84%
42,216
– –
RMD icon
50
ResMed
RMD
$30.3B
$3.43M 0.84%
16,125
– –
1
2
3 4 5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Capital Impact Advisors held 129 positions worth $407M, up 21% from $337M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital Impact Advisors withdrew a net $22.2M in Q4 2020, closing 27 positions and reducing 20 holdings. Its most notable exit was Livongo Health, Inc. Common Stock, an estimated $6.86M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Capital Impact Advisors opened a new position in Veracyte worth $8.81M.

  • Capital Impact Advisors's largest Q4 2020 buy was Veracyte: 180,000 shares worth $8.81M.
  • Capital Impact Advisors added most to Twist Bioscience in Q4 2020, an estimated $6.32M increase.
  • Capital Impact Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $11.4M.
  • Capital Impact Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $6.86M.
  • Capital Impact Advisors's ten largest holdings make up 24% of its $407M portfolio in Q4 2020.
  • Capital Impact Advisors opened 20 new positions and closed 27 in Q4 2020.
  • Capital Impact Advisors's portfolio value rose 21% quarter-over-quarter to $407M.

Based on Capital Impact Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.